CXCL8 and Sepsis: This meta-analysis demonstrated that ulinastatin significantly reduces mortality and inflammatory markers such as CRP, IL-1β, IL-6, IL-8, IL-10, PCT, and TNF-α in patients with sepsis compared to control group.